Showing results (1431-1440 of 1,619) with videos related to

Sort By:
Pageof 162
Gynecologic Oncology|June 28, 2015
Development of a risk stratification system to guide treatment for female germ cell tumorsJane L Meisel, Kaitlin M Woo, Nora Sudarsan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 17, 2021
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III StudySteven R Feldman, Nataliya Reznichenko, Grazyna Pulka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1995
Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesisH Manzone, P C Billings, W N Cummings, et al.
The Journal of Dermatological Treatment|March 6, 2012
Nonmelanoma skin cancer treatment training varies across different medical specialistsPhoebe C M Romero, Megan A Kinney, Sarah L Taylor, et al.
Journal of Agricultural Safety and Health|December 14, 2007
Diagnosed skin diseases among migrant farmworkers in North Carolina: prevalence and risk factorsT A Arcury, S R Feldman, M R Schulz, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Coevolution with toxic prey produces functional trade-offs in sodium channels of predatory snakesRobert E Del Carlo, Jessica S Reimche, Haley A Moniz, et al.
The American Journal of Cardiology|May 12, 2001
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular functionB Pitt, B O'Neill, R Feldman, et al.
Physical Therapy|March 17, 2012
Neuromuscular electrical stimulation for intensive care unit-acquired weakness: protocol and methodological implications for a randomized, sham-controlled, phase II trialMichelle E Kho, Alexander D Truong, Roy G Brower, et al.
Clinical Genitourinary Cancer|September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted DrugsChung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologiesM H Voss, D A Bastos, C A Karlo, et al.
Pageof 162